DIAGONAL BIO AB |
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0298 SEK | -3.56% |
|
-4.18% | -91.56% |
| 05-31 | Diagonal Bio AB Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
| 05-23 | Diagonal Bio AB Appoints Fata Mrsic as Chief Financial Officer, Effective June 14, 2024 | CI |
Chart: Technical Analysis
Technical analysis trends
| Short Term | Mid-Term | Long Term | |
|---|---|---|---|
| Trend | Bearish | Bearish | Bearish |
| Resistance | 0.0590 | 0.1200 | 0.1100 |
| Spread/Res. | -49.49% | -75.17% | -72.91% |
| Spread/Supp. | -0.67% | -0.67% | -3.25% |
| Support | 0.0300 | 0.0300 | 0.0308 |
- Stock Market
- Equities
- DIABIO Stock
- Charts Diagonal Bio AB
